Bio-Rad Laboratories Shares Fall on 4Q Sales Miss, Cost-Cutting Plans
Bio-Rad Laboratories' cost-cutting plans come as the company swung to a loss in the fourth quarter amid lower sales across its life-science segment. The company posted a net loss of $715.8 million, or ...
Moderna is counting on its product pipeline to resuscitate its ailing stock
Moderna is now expecting 2025 research and development costs of about $4.1 billion and selling, general and administrative costs of about $1.1 billion. Cost of sales is expected to come to about $1.2 ...
S&P 500 on pace to snap back-to-back weekly declines as 3-day weekend nears
The S&P 500 was up so far this week, rebounding from back-to-back weekly declines, ahead of a 3-day holiday weekend in the U.S. The S&P 500 was flat in late afternoon trade at around 6,112, shy of its ...
Investor's Business Daily on MSN23h
Howmet Aerospace, IBD Stock Of The Day, Unfazed By Trump Defense Budget Comments
Howmet Aerospace breaks out to record highs after earnings. Defense stocks pull back after Trump proposes 50% budget cut.
DaVita’s stock leads S&P 500 decliners after Berkshire pares stake. Its soft guidance isn’t helping.
DaVita shares were tumbling 13.5% Friday to lead S&P 500 decliners, after Warren Buffett’s Berkshire Hathaway pared its stake in the provider of kidney dialysis.